`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`ADAMIS PHARMACEUTICALS CORPORATION
`Petitioner
`
`v.
`
`BELCHER PHARMACEUTICALS, LLC
`Patent Owner
`
`_____________________
`CASE: IPR2019-01021
`U.S. PATENT NO. 9,283,197
`_____________________
`
`
`JOINT REQUEST TO TREAT SETTLEMENT AND LICENSE
`AGREEMENT AS BUSINESS CONFIDENTIAL INFORMATION AND TO
`MAINTAIN SAID AGREEMENT SEPARATE FROM THE PUBLIC FILE
`PURSUANT TO 35 U.S.C. § 317(b) AND 37 C.F.R. § 42.74(c)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2019-01021
`U.S. Patent No. 9,283,197
`
`Pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c), and the Board’s
`
`authorization of July 26, 2019, Petitioner Adamis Pharmaceuticals Corporation,
`
`LLC and Patent Owner Belcher Pharmaceuticals, LLC jointly request to treat as
`
`business confidential information the true copy of the Settlement and License
`
`Agreement (Confidential Exhibit 1026) between the parties, as referenced in the
`
`parties’ Joint Motion to Terminate Pursuant to 35 U.S.C. § 317 and 37 C.F.R. §
`
`42.74, filed concurrently herewith.
`
`35 U.S.C. § 317(b) provides that:
`
`At the request of a party to the proceeding, the agreement
`or understanding shall be treated as business confidential
`information, shall be kept separate from the file of the
`involved patents, and shall be made available only to
`Federal Government agencies on written request, or to any
`person on a showing of good cause.
`
`Likewise, 37 C.F.R. § 42.74(c) provides that:
`
`A party to a settlement may request that the settlement be
`treated as business confidential information and be kept
`separate from the files of an involved patent or application.
`The request must be filed with the settlement. If a timely
`request is filed, the settlement shall only be available:
`
`(1) To a Government agency on written request to the
`Board; or
`
`
`
`1
`
`
`
`Case No. IPR2019-01021
`U.S. Patent No. 9,283,197
`
`
`(2) To any other person upon written request to the
`Board to make the settlement agreement available,
`along with the fee specified in § 42.15(d) and on a
`showing of good cause.
`
`The present request, which is being filed contemporaneously with the
`
`Settlement and License Agreement, is timely and in accordance with the foregoing
`
`authority. Therefore, the parties request that the Settlement and License Agreement
`
`(Confidential Exhibit 1026) (i) be treated as business confidential information, (ii)
`
`be maintained separate from the publicly available file of the involved patent, and
`
`(iii) shall be made available only to Federal Government agencies on written request,
`
`or to persons showing good cause on written request, pursuant to 35 U.S.C. § 317(b)
`
`and 37 C.F.R. § 42.74(c).
`
`
`Dated: July 29, 2019
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Jason A. Engel/
`Jason A. Engel
`Reg. No. 51,654
`Customer No. 24573
`Jason.Engel.PTAB@klgates.com
`T: (312) 807-4236
`F: (312) 827-8145
`K&L Gates LLP
`70 W. Madison Street, Suite 3100
`Chicago, IL 60602
`
`Counsel for Petitioner
`
`
`
`
`
`2
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that on July 29, 2019, a true and correct copy
`
`of the foregoing JOINT REQUEST TO TREAT SETTLEMENT AND
`
`LICENSE AGREEMENT AS BUSINESS CONFIDENTIAL INFORMATION
`
`AND TO MAINTAIN SAID AGREEMENT SEPARATE FROM THE
`
`PUBLIC FILE PURSUANT TO 35 U.S.C. § 317(b) AND 37 C.F.R. § 42.74(c)
`
`was served via electronic mail on the following counsel of record for Patent Owner:
`
`
`
`
`
`
`
`
`
`
`
`
`
`Cole Y. Carlson
`cole.carlson@gray-robinson.com
`Stefan V. Stein
`stefan.stein@gray-robinson.com
`ptotpa@gray-robinson.com
`GrayRobinson, P.A.
`401 E. Jackson Street, Suite 2700
`Tampa, FL 33602
`Telephone: (813) 273-5000
`
`By:
`
`/Jason A. Engel/
`Jason A. Engel
`Reg. No. 51,654
`Customer No. 24573
`Jason.Engel.PTAB@klgates.com
`T: (312) 807-4236
`F: (312) 827-8145
`K&L Gates LLP
`70 W. Madison Street, Suite 3100
`Chicago, IL 60602
`
`
`
`